Hytest is excited to announce the launch of its recombinant HCV NS3 antigen (Cat. # 8HC53)—a high-purity reagent developed as capture or detection material for in vitro immunoassays aimed at the qualitative detection of antibodies to Hepatitis C Virus (HCV).

This antigen is designed to support assay developers and diagnostic manufacturers working on ELISA, LF, and CLIA platforms, offering excellent consistency, sensitivity, and specificity for serological test development.

The HCV NS3 protein is one of the key immunodominant antigens used in commercial assays and plays an essential role in supporting early and accurate detection of HCV infections, aligning with global initiatives for broader screening and early intervention.

This launch reinforces Hytest’s ongoing commitment to expanding its infectious disease reagent portfolio to support the development of high-quality diagnostic solutions worldwide.

Read more from the product page

See also our infectious diseases campaign